Possible site of action of CGRP antagonists in migraine. - Wikidata - awgldk - TriplyDB

Possible site of action of CGRP antagonists in migraine.

Possible site of action of CGRP antagonists in migraine.

http://www.wikidata.org/entity/Q34169056

about

CGRP as a neuropeptide in migraine: lessons from mice Calcitonin gene-related peptide: physiology and pathophysiology Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist.CGRP receptor antagonists: an expanding drug class for acute migraine?Calcitonin gene-related peptide (CGRP): a new target for migraine A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca2+ levels in the perfused and non-perfused isolated rat middle cerebral artery.CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?Chronic migraine treatment: from OnabotulinumtoxinA onwards.The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.Cerebellar Atrophy and Changes in Cytokines Associated with the CACNA1A R583Q Mutation in a Russian Familial Hemiplegic Migraine Type 1 Family.Side effects associated with current and prospective antimigraine pharmacotherapies.Effect of a calcitonin gene-related peptide-binding L-RNA aptamer on neuronal activity in the rat spinal trigeminal nucleus.Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy.Novel capsaicin-induced parameters of microcirculation in migraine patients revealed by imaging photoplethysmography.

P2860

Q26821821-EDC922D9-DD16-4486-A0AF-21C24AE3ACCC Q28249298-2EDF6110-FE76-4226-A3D2-9006CC7AAADA Q30466408-5C014378-93CF-4A7C-BEF0-95E736047773 Q34304978-F4F32CA3-D67C-419B-B4F1-0AA96901FAE2 Q34446715-2A058D8B-4402-4DCD-A652-01EBE19CF3EE Q34637610-6B609E6C-FADD-40D4-8102-681CF032A0F7 Q35358428-D4A21703-C99C-43AD-B6F9-1B62F7A4EFD4 Q35777253-08C83A58-9488-4E18-8853-1121FA1109E3 Q36340711-C5B54492-B1E2-4684-B75A-F452B4BC23A8 Q36385789-46782BD6-558E-4FDC-A4E9-47D99E016A02 Q37337815-F6A091E5-D08D-4AFB-A1C7-BE353CDBCC5E Q38866988-9C3CF180-4F64-4FDD-8F1C-133FF259B17E Q41829270-B12F44F9-9DCB-4879-8633-E0649D3C5F04 Q45896152-26BC4D92-3A4B-454F-9C24-1085A09A1A07 Q47309054-7FA765B1-1F1E-427F-80C6-BCC5C8E70D9F Q50041816-122FBA8D-1B6F-46F2-92F1-6B6303AB61EF Q55084349-3D6FA67C-30A4-4779-8BE4-F5946B32B8FF Q55407206-246DD323-07EA-4B04-8696-E149554CDC7C

P2860

Possible site of action of CGRP antagonists in migraine.

http://www.wikidata.org/entity/Q34169056

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Possible site of action of CGRP antagonists in migraine.

@ast

Possible site of action of CGRP antagonists in migraine.

@en

Possible site of action of CGRP antagonists in migraine.

@nl

type

label

Possible site of action of CGRP antagonists in migraine.

@ast

Possible site of action of CGRP antagonists in migraine.

@en

Possible site of action of CGRP antagonists in migraine.

@nl

prefLabel

Possible site of action of CGRP antagonists in migraine.

@ast

Possible site of action of CGRP antagonists in migraine.

@en

Possible site of action of CGRP antagonists in migraine.

@nl

P1433

Q34169056-22980E0A-B5AA-4E45-A83C-BBB2CBF36A8A

P1476

Q34169056-751616B9-B444-4E52-B57E-0A1A1FC0D65E

P2860

Q34169056-0AA999B8-912B-4DC4-8FE6-52BF5B82DA7F

Q34169056-1650B962-8608-4BF2-AF86-C553B373D50E

Q34169056-16DD8A7B-86D2-4550-B8F5-9D67FE5F632A

Q34169056-33649DF1-DF1C-4B61-8E56-84445D2A3DD2

Q34169056-35CBE227-9407-44B5-BBDC-74BEE5E24421

Q34169056-374F13DE-E6D7-49F7-91E9-C2AB8488F5DF

Q34169056-3D459682-D4E2-4295-9B05-68DD52798255

Q34169056-40BAAEE7-CE54-4A2A-A363-A29DFC08C16A

Q34169056-429DF7E6-E3CB-4210-864E-53D918A26F88

Q34169056-59DB3743-9423-4EB3-82AD-42066AA386B6

P304

Q34169056-F1DC25DF-9086-42D6-8693-D65D381FF3CE

P31

Q34169056-E2995A72-C808-4D95-A6DC-81DE3AD33779

P356

Q34169056-90E9BD3E-6520-4DCB-A625-65C07A52299F

P407

Q34169056-B698C43C-0AE5-43AA-9D83-060AFCB68763

P433

Q34169056-03E235EE-993E-44D2-911C-6B9DFDB9AFCE

P478

Q34169056-1DE3548B-2208-44E3-AC6B-1006254ACD03

P50

Q34169056-1BBAFF61-A693-472F-8887-B17A60308B9F

Q34169056-8AC3791F-E368-490B-8339-58BF36CC6516

P577

Q34169056-BE9AB2C2-5664-4FA7-9587-8BCC139EE2E7

P698

Q34169056-8B425E58-AFB8-43DB-A812-BD55054340A0

P921

Q34169056-6719b79c-4384-86b9-efed-48b42d38a42f

P356

0333102411398403

P1433

P1476

Possible site of action of CGRP antagonists in migraine.

@en

P2860

BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.

Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist.

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

Origin of pain in migraine: evidence for peripheral sensitisation.

P304

748-750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0333102411398403

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Peer Carsten Tfelt-Hansen

P577

2011-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21383046

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder